Nucleophosmin (NPM1) is a protein biomarker that can reflect the therapeutic effect of chemotherapy [17], which not only has the function of monitoring the progression in hematological diseases [18, 19], but also has differential expression in some solid tumors such as colon cancer [20] and lung adenocarcinoma [21]. This evidence concerns the gene NPM1 and malignant colon neoplasm.